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recombination
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Alexander Lorenz‡, Claire Bryer and Matthew C. Whitby
Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK1. Summary
Thehistone-fold proteinsMhf1/CENP-S andMhf2/CENP-Xperform two impor-
tant functions in vertebrate cells. First, they are components of the constitutive
centromere-associated network, aiding kinetochore assembly and function.
Second, they work with the FANCM DNA translocase to promote DNA repair.
However, it has been unclear whether there is crosstalk between these roles.
We show that Mhf1 andMhf2 in fission yeast, as in vertebrates, serve a dual func-
tion, aidingDNA repair/recombination and localizing to centromeres to promote
chromosome segregation. Importantly, these functions are distinct, with the
former being dependent on their interaction with the FANCM orthologue Fml1
and the latter not. Together with Fml1, they play a second role in aiding chromo-
some segregation by processing sister chromatid junctions. However, a failure of
this activity does not manifest dramatically increased levels of chromosome mis-
segregation due to the Mus81–Eme1 endonuclease, which acts as a failsafe to
resolve DNA junctions before the end of mitosis.2. Introduction
Homologous recombination (HR) is a fundamental process in chromosome
biology, being deployed in various ways to facilitate the repair and tolerance
of DNA lesions in which genetic information is lost or corrupted in both strands
of the double helix (e.g. a DNA double-strand break; DSB). It also promotes
genome duplication by enabling the restart of collapsed replication forks, and
in most studied eukaryotes serves a crucial role during meiosis in establishing
chiasmata that guide correct disjunction of the homologous chromosomes
during the first meiotic division. A potential consequence of its action is the
rearrangement of genetic material, which in the germline can have the desirable
effect of driving genetic diversity, but in somatic cells can lead to the loss or
alteration of gene function, which in turn can result in disease and death.
Many proteins contribute to the correct functioning of HR; however, among
these are a core cohort that is directly responsible for catalysing the keyDNA trans-
actions that occur [1]. Included here are nucleases and DNA helicases that often
work hand in hand to generate a region of single-stranded DNA (ssDNA) with
an exposed 30-OH terminus onto which the central recombinase Rad51 can load
supported by various mediator and accessory proteins. Once bound, Rad51 cata-
lyses invasion of its DNA into an intact homologous duplex, forming a
displacement (D) loop where the 30 end of the invading strand can be used to
prime DNA synthesis. The end stages of HR involve either the dissociation or
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2cleavage of the D-loop or its maturation into one or two
Holliday junctions (HJs) that similarly can be processed by a
variety of DNA helicases/translocases and structure-specific
nucleases to disengage the recombining DNA molecules,
enabling them to segregate during mitosis/meiosis.
One of the core components of the HR machinery is the
FANCM DNA translocase [2–4]. In humans, FANCM is
encoded by one of 15 genes in which mutations can cause the
rare genetic disease Fanconi anaemia (FA), characterized by
progressive bone marrow failure, developmental problems
and cancer proneness. At a cellular level, deficiencies in FA pro-
teins result in hypersentivity to DNA interstrand cross-linking
(ICL) agents such as cisplatin, increased chromosomal abnorm-
alities, increased DNAbridges duringmitosis, and high rates of
bi- and multinucleated cells that result from failed cytokinesis
[5]. The products of the FA genes are part of a DNA repair net-
workwith eightmembers (FANCA, -B, -C, -E, -F, -G, -L and -M),
forming the so-called FA core complex that monoubiquitinates
FANCD2 and FANCI, which in turn are thought to direct sub-
sequent repair events involving HR and translesion DNA
synthesis [6]. FANCM’s role here is to target the core complex
to sites of stalled replication, which promotes the monoubiqui-
tination reaction [2,7–9]. However, various lines of evidence
also point to key roles for FANCM in HR that are independent
of core complex activation and FANCD2/Imonoubiquitination
[4]. Not least among these are studies of the yeast orthologues
of FANCM (Mph1 in Saccharomyces cerevisiae and Fml1 in
Schizosaccharomyces pombe), which operate in environments
that are devoid of most other FA proteins.
FANCM, Mph1 and Fml1 are superfamily 2 DNA heli-
cases/translocases, and in vitro can use the energy from
hydrolysing ATP to drive fork remodelling, HJ branch
migration and D-loop dissociation [10–15]. Based on the find-
ings of cell biological and genetic experiments, it is thought
that these activities are used to support at least two reactions
related to HR in vivo, namely the reversal of stalled replication
forks (which could be used to generate a substrate for HR
to promote replication restart) and the processing of recombi-
nation intermediates that enables the recombining DNAs
to disjoin. In the latter case, several studies have shown
that FANCM and its orthologues can limit the formation of
crossover (CO) recombinants that stem from the cleavage
of D-loops/HJs by structure-specific nucleases such as
Mus81–Eme1 [12–14,16–20]. COs are reciprocal exchanges
of the chromosomal regions that flank the site at which HR
has acted. In meiotic cells, they are necessary for the establish-
ment of chiasmata, but in somatic cells they can result in
deleterious genome rearrangements if the recombining
DNAs are other than perfectly aligned sister chromatids. The
ability of FANCM/Mph1/Fml1 to direct CO avoidance most
probably relates to its D-loop dissociation activity, which
negates the need for junction resolution by a nuclease, and,
in the context of a DSB, drives repair via a sub-pathway of
HRcalled synthesis-dependent strand annealing that generates
only non-crossover (NCO) recombinants.
Recently, itwas found that FANCMinteractswith a complex
of two small histone-fold proteins named MHF1 and MHF2
(i.e. FANCM-associated Histone-Fold protein 1 and 2) [21,22].
The interaction occurs via a region just on the C-terminal side
of FANCM’s helicase domain, which docks onto a hetero-
tetramer configuration of MHF1 and MHF2 that resembles the
H3–H4heterotetramerwithinhistoneoctamers [23]. Forbrevity,
wewill refer to both theyeast andhuman formof this complex asMHF henceforth. Genetic studies inHeLa and/or chicken DT40
cells have shown thatMHF functions alongside FANCM in pro-
moting FANCD2 monoubiquitination following induction of
ICLs, and suppressing spontaneous sister chromatid exchange
(SCE), albeit in the latter case not to the same extent as
FANCM [21,22]. At least in part, it appears to fulfil these roles
by promoting the stability, chromatin association and substrate
targeting of FANCM. In vitro purified MHF binds to double-
stranded DNA (dsDNA) and enhances the fork reversal activity
of FANCM [21,22]. Intriguingly, there is a synergistic increase in
theDNAbinding activityof theFANCM–MHFcomplex, result-
ing from the establishment of an additional DNA binding site,
which is presumably important for substrate targeting [22,23].
Interestingly, MHF1 and MHF2 are also components of
the constitutive-centromere-associated network (CCAN),
going under the names of CENP-S and CENP-X, respectively
[24,25]. Here, they interact with CENP-T and CENP-W to
form a stable heterotetramer that can wrap DNA around
itself in a manner that is thought to be analogous to the tetra-
some formed by the histone H3–H4 heterotetramer [25].
CENP-T interacts directly with the Ndc80 complex of the
outer kinetochore, which in turn attaches to the microtubules
of the mitotic spindle [26–28]. In this way, CENP-T-W-S-X is
thought to form a point of anchorage for the kinetochore at
the centromere that is additional to that formed by the inter-
action of Ndc80 to CENP-A-containing nucleosomes via
Mis12 and CENP-C. DT40 cells deficient in MHF exhibit
noticeable defects in kinetochore architecture, including
reduced localization of Ndc80 to the outer kinetochore and
an increase in the intrakinetochore distance between CENP-
T and Ndc80, and depletion of MHF2 in HeLa cells results
in numerous mitotic defects, including a high proportion of
misaligned chromosomes at the metaphase plate [24].
To gain a greater understanding of MHF’s roles in DNA
recombination and repair, and how this relates to its function
at the centromere, we have conducted a genetic and biochemical
analysis of S. pombe MHF. We show that MHF’s DNA repair/
recombination role is distinct from its centromeric role, with
the former depending largely on its physical interaction with
Fml1 and the latter being independent of Fml1. We also reveal
that MHF is recruited to DNA bridges and trailing segments
of DNA during mitosis in a Fml1-dependent manner. Impair-
ment of Fml1’s catalytic activity or interaction with MHF
increases the frequency of mitotic DNA bridges, but relatively
few of these lead to gross chromosome missegregation, see-
mingly due to processing by the Mus81–Eme1 endonuclease.
Our data indicate that unresolved recombination intermediates
often persist into mitosis and are processed by Fml1–MHF or
Mus81–Eme1 even as late as anaphase/telophase.3. Results
3.1. Mhf1 and Mhf2 localize to centromeres, and
are needed for correct chromosome segregation
during meiosis
In contrast to fml1, deletion of either mhf1 or mhf2 in fission
yeast results in a marked reduction in growth and viability
indicating that MHF performs a critical function that does
not require Fml1 (figure 1a). Epifluorescence microscopy of
strains expressing GFP-tagged forms of Mhf1 and Mhf2
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Figure 1. MHF functions at the centromere and promotes viability and chromosome segregation independently of Fml1. (a) Spot assay showing the relative growth
of strains MCW1221, MCW2080, MCW4639 and MCW4777 on YES agar after 3 days at 308C. (b) Example cells from a culture of MCW5846 showing the co-
localization of Mhf1-GFP with Mis6-mCherry. (c) Schematic of the meiotic chromosome segregation assay. (d ) Meiotic chromosome segregation in asci from
wild-type (AY167-1D  FO652), fml1D (MCW4172  MCW6196) and mhf2D (MCW4777  MCW5113) homozygous crosses.
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3show that they co-localize with the CCAN component Mis6
(CENP-I), confirming that Mhf1 and Mhf2 are centromeric
proteins in fission yeast (figure 1b; electronic supplementary
material, figure S1). Analysis of meiotic chromosome segre-
gation using strains in which chromosome 2 is marked with
an array of lacO sequences bound by the LacI repressor
protein fused to GFP showed that deletion of mhf2 results
in a high proportion of meiosis I and II segregation defects
(figure 1c,d). By contrast, a fml1D mutant exhibits almost
wild-type levels of accuracy for meiotic chromosome segre-
gation (figure 1d ). Altogether these data are consistent with
the notions that MHF plays an important role at the centro-
mere in establishing proper kinetochore function, which
is needed for faithful chromosome segregation, and that
this function is independent of its involvement with Fml1
in recombination.3.2. MHF interacts with the C-terminal region of Fml1
Human MHF binds to a region on the C-terminal side of
FANCM’s helicase domain [22,23]. To see whether the same is
true for the fission yeast orthologues, we established an in vitro
assay for determining their interaction using purified MHF
(figure 2; electronic supplementary material, figure S2A) and
Fml1 fused to maltose binding protein (MBP). Essentially,
MBP-Fml1 bound to amylose resin was tested for its ability
to retain MHF on the resin, with detection of the complex on a
Western blot using an antibody against a His-tag fused to
Mhf2. As expected, full-length Fml1, which is 834 amino acids
(figure 2a), retained MHF on the resin, whereas MBP or resin
alone did not (figure 2b). We next tested various fragments of
Fml1 for their ability to bind MHF; by this approach, we nar-
rowed down the point of interaction to a region between
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Figure 2. MHF interacts with Fml1. (a) Schematic of Fml1 and the various truncated forms of it used in (b) and (c). The position of the MBP fusion, DNA helicase
motifs (blue bars), and region encompassing the site of MHF interaction (red box) are shown. The numbers refer to amino acid positions. (b–d) Western blots
showing the amount of His-tagged Mhf2 retained on amylose resin that has been pre-incubated with the indicated MBP-Fml1 fragment (the numbers refer to
amino acid positions). (e) Amino acids 670–690 in Fml1 with the mutations tested in ( f ) indicated. ( f ) Western blot showing the retention of His-tagged Mhf2 on
amylose resin pre-incubated with MBP-Fml1650– 690 or its mutant derivatives 1–3. (g) Western blot showing that full-length Fml1AAA fused to MBP fails to retain
HisMhf2 on amylose resin. (h) SDS-PAGE analysis of gel filtration fractions 32–38 from the purification of the Fml1576 – 725–MHF complex. The gel was stained
with Coomassie blue. (i) EMSA comparing the ability of MHF and the Fml1576– 725–MHF complex to bind linear dsDNA. The amounts of protein are 49 nM (lanes b
and f ), 98 nM (lanes c and g), 490 nM (lanes d and h) and 980 nM (lanes e and i).
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4amino acids, 620 and 700 (figure 2a,b; electronic supplementary
material, figure S2B,C). Further division of this region estab-
lished that amino acids 650–690 encompassed the site of
interaction (figure 2c), and that amino acids 670–690 are suffi-
cient to retain MHF on the resin, but only under conditions of
limited washing (figure 2d). To identify key residues needed
for the interaction,we chose tomutate the tyrosine and arginines
in the 670–690 region to alanine as such changes have been
shown to frequently disturb protein–protein interactions in
other cases [29] (figure 2e). Three combinations of mutations
were tested, and whereas changing arginines 683, 686 and 687
to alanine had no effect on the ability of the 650–690 amino
acid fragment to interact with MHF, changing tyrosine 672
together with arginines 674 and 678 to alanine totally abolishedbinding both in the context of the 650–690 amino acid fragment
and the full-length protein (figure 2f,g).
3.3. MHF’s ability to bind dsDNA appears to be
enhanced by its interaction with Fml1’s
C-terminal domain
It has recently been shown that the interaction between human
MHFand FANCMgenerates a DNAbinding site, which results
in a synergistic increase in DNA binding of the protein complex
[23]. To see whether the same is true for S. pombe MHF and
Fml1, we co-expressed Fml1’s C-terminal domain (residues
576–725) with Mhf1 and His-tagged Mhf2 in Escherichia coli
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Figure 3. MHF functions with Fml1 in the same DNA damage tolerance/
repair pathway. (a) Spot assays comparing the growth and genotoxin sensi-
tivities after 5 days of growth at 308C for (a) strains MCW1221, MCW2080,
MCW4639, MCW4777, MCW5127, MCW5790 and MCW5126, and (b) strains
MCW1221, MCW2080, MCW5895 and MCW4405.
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5and purified the complex by nickel affinity and gel filtration
chromatography (figure 2h).We then compared the DNAbind-
ing ability of this complex to that of the MHF complex using
an electrophoretic mobility shift assay (EMSA; figure 2i). The
MHF complex without Fml1576–725 binds a 50 bp linear
dsDNA to form a single retarded band at relatively high protein
concentrations (greater than 1.48 mM; electronic supplementary
material, figure S2D). By contrast, much lower concentra-
tions of the MHF–Fml1576–725 complex (less than or equal
to 490 nM) can achieve the same amount of DNA binding,
consistent with the idea that the interaction between MHF
and Fml1 forges an additional DNA binding site (figure 2i,
lanes h and i). However, a caveat to this experiment is that we
were unable to purify Fml1576–725 to homogeneity and therefore
are uncertain whether or not this region of Fml1 binds DNA in
its own right.
3.4. Fml1’s ability to interact with MHF is important
but not essential for its role in DNA repair
We have previously shown that Fml1 is needed for the
repair/tolerance of DNA damage induced by the alkylating
agent methyl methanesulfonate (MMS) and the DNA ICL
agent cisplatin [12,14]. To see whether MHF also plays a
role here alongside Fml1, we compared the MMS and cispla-
tin sensitivities of fml1D, mhf1D and mhf2D single and double
mutant strains (figure 3a). As described earlier, both mhf1D
and mhf2D mutants exhibit poor growth, and our data here
show that this is not worsened when they are combined
together or with fml1D. The poor growth hampers the com-
parison of genotoxin sensitivities, but nevertheless it is clear
that both mhf1D and mhf2D exhibit similar levels of hypersen-
sitivity to MMS and cisplatin, which is not further enhanced
when combined with fml1D. This epistatic relationship indi-
cates that MHF and Fml1 function in the same pathway for
the repair/tolerance of ICLs and MMS-induced damage.
To see how important the interaction between Fml1 and
MHF is for their ability to promote DNA repair, we com-
pared the MMS and cisplatin sensitivities of a fml1D strain
with one in which Y672, R674 and R678 in fml1 were mutated
to alanine and a natMX4 marker inserted adjacent to its 30
untranslated region ( fml1AAA::natMX4; figure 3b). Interest-
ingly, the fml1AAA mutant, although hypersensitive to MMS
and cisplatin, is not as sensitive as a fml1D mutant. However,
it exhibits the same sensitivity as a strain containing a trun-
cated form of Fml1, in which the entire C-terminal domain
from amino acid 604–834 is deleted ( fml1DC1–603). Impor-
tantly, the hypersensitivity of both fml1AAA and fml1DC1–603
mutants is not due to an altered level of Fml1 protein (see
electronic supplementary material, figure S3) nor to the pres-
ence of the linked natMX4 marker in these strains [12].
Together these data indicate that the critical role of Fml1’s
C-terminal domain is to mediate the interaction with MHF,
and that without this Fml1 is still able to promote DNA
repair, albeit at a reduced efficiency.
3.5. MHF functions with Fml1 to promote
non-crossover recombination
Fml1 plays a major role in promoting NCO recombination
both in mitotic and meiotic cells, and at least in the latter
case MHF is also involved [19]. To further investigate theinvolvement of MHF in promoting NCO recombination, we
used a plasmid gap repair assay, in which a plasmid contain-
ing a double-stranded gap within a copy of ade6 is repaired
by HR with a mutant copy (ade6-M26) on chromosome III,
resulting in integration of the plasmid into the chromosome
(CO) or recircularization of the plasmid (NCO) (figure 4a)
[14]. In a wild-type strain, approximately 75% of the repaired
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Figure 4. MHF promotes NCO recombination in both mitotic and meiotic cells. (a) Schematic of the plasmid gap repair assay. The filled circle indicates the position
of the M26 mutation. (b) Percentage of Adeþ transformants that are COs in strains MCW1193, MCW2096, MCW5345, MCW5346, MCW5790, MCW5983, MCW4893
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6plasmids contain a fully restored copy of ade6þ resulting from
a gene conversion (GC) event and only 10% of these are COs
(figure 4b; electronic supplementary material, figure S4).
A comparison of fml1D, mhf1D and mhf2D single and
double mutants showed that they all exhibit wild-type
levels of GC and gap repair, but, unlike wild-type, approxi-
mately 35% of adeþ recombinants are COs (figure 4b;
electronic supplementary material, figure S4). The similarity
in the percentage of COs in both single and double mutant
strains indicates that MHF plays an essential role in the
Fml1-dependent pathway of NCO recombination in mitotic
cells. Interestingly, the fml1AAA mutant exhibits only approxi-
mately 20% COs among adeþ recombinants (figure 4b), which
suggests that MHF may not need to interact with Fml1 in
order to provide at least some assistance in promoting
NCO recombination in mitotic cells.
MHF supports Fml1 in directing NCO recombination
during meiosis [19]. To see whether the interaction between
these proteins is important for this, we compared the percen-
tage of COs associated with GC at the ade6-3083 meiotic
recombination hotspot in wild-type, fml1D and fml1AAA strains(figure 4c,d; electronic supplementary material, table S1).
As seen previously, there is a small but significant increase
in the percentage of COs associated with GC in a fml1D
mutant compared with wild-type. A similar increase is also
seen in the fml1AAA mutant, indicating that the interaction
between Fml1 and MHF is important for directing NCO
recombination during meiosis.3.6. MHF functions with Fml1 to promote gene
conversion at blocked replication forks
Replication fork stalling at the RTS1 protein–DNA barrier
induces Rad51-dependent recombination, which can give rise
to both GC (conversion-types) and deletions (deletion-types)
between flanking ade62 heteroalleles (figure 5a) [30]. Fml1
plays a role here in promoting GC, probably by catalysing
the reversal of the stalled fork, and recent work has implicated
Mhf2 in assisting it in this function [12,14,22]. To confirm that
MHF works with Fml1 in promoting GC at the RTS1 barrier,
we compared the frequency of adeþ deletion- and conversion-
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MCW5217, MCW5218, MCW5220, MCW4797 and MCW5932. All values are mean+s.d. Statistical significance in comparison with wild-type and fml1þ::natMX4 is
*p , 0.01 and **p , 0.001.
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7types in fml1D, mhf1D and mhf2D single and double mutant
strains, and in the fml1AAA mutant (figure 5b,c). Consistent
with published data, absence of fml1 has no effect on the fre-
quency of deletion-types, but reduces conversion-types by
approximately sevenfold. Both mhf1D and mhf2D single
mutants likewise show a reduction (approx. threefold) in con-
version-type frequency, but interestingly exhibit a small
increase in deletion-types. Importantly, both fml1D mhf1D
and fml1D mhf2D double mutants exhibit essentially the same
deletion-type and conversion-type frequency as a fml1D
single mutant. Similar to what was seen in the plasmid gap
repair assay, the fml1AAA mutant exhibits a more modest
effect on recombination than fml1D, with a reduction in conver-
sion-types of twofold when compared with a fml1þ::natMX4
strain, which exhibits slightly higher recombinant frequencies
than a wild-type without the natMX4 marker. Altogether
these data indicate that MHF promotes Fml1-dependent GC
at stalled replication forks, and can do so at a reduced level
even when unable to interact with Fml1’s C-terminal
domain. In the absence of MHF, Fml1 retains some ability to
act but at a much reduced efficiency. Moreover, withoutMHF Fml1 may act in an aberrant fashion to promote the
formation of deletion-types.3.7. MHF localizes to non-centromeric sites in a Fml1-
dependent fashion
As shown in figure 1b, Mhf1-GFP co-localizes with the cen-
tromeric protein Mis6, consistent with it being a component
of the CCAN. However, unlike Mis6, it also forms a speckling
of fluorescence throughout the rest of the nucleus, which
might represent its localization to sites across the genome
where Fml1 is actively engaged in DNA repair and recombi-
nation. To investigate this, we assessed whether Mhf1-GFP
localization is affected by deletion of fml1 (figure 6; electronic
supplementary material, figure S5). In a fml1D strain, Mhf1-
GFP centromeric localization appears unaltered. By contrast,
its wider distribution throughout the nucleus is lost or greatly
diminished in almost all cells, and this is also true in a
fml1AAA strain. This loss in general nuclear fluorescence is
not due to a change in the amount of Mhf1-GFP, which is
phase
wild-type fml1D fml1AAA fml1D196N
DAPI
Mhf1-GFP
Mis6-mCherry
Mhf1-GFP
Mhf1-GFP +
+ DAPI
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Figure 6. Nuclear localization of Mhf1-GFP in wild-type and fml1 mutant cells. The strains are MCW5846, MCW5963, MCW6152 and MCW6132.
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8the same in both wild-type and fml1 mutant strains (see elec-
tronic supplementary material, figure S6). To see whether
the non-centromeric localization of MHF is dependent on
Fml1’s catalytic activity, we assessed Mhf1-GFP fluorescence
in a fml1D196N strain, which contains a mutation in Fml1’s heli-
case motif II that destroys its ATPase activity (and therefore its
ability to unwind and branchmigrate DNA junctions) without
affecting its DNA binding [12]. Similar to the wild-type strain,
Mhf1-GFP localized to both centromeric and non-centromeric
sites throughout the nuclei of fml1D196N mutant cells (figure 6;
electronic supplementary material, figure S5). Altogether
these data indicate that MHF is recruited to and/or retained
at non-centromeric chromosomal sites through its interaction
with Fml1.3.8. Fml1 limits mitotic bridge and tail formation
In human cells, the FA pathway plays a role in limiting the
occurrence of DNA bridges connecting segregating sister
chromatids during mitosis [31]. To see whether Fml1 plays
a similar role in S. pombe, we analysed binucleate cells from
asynchronously growing cultures of wild-type and fml1D
strains, using DAPI to stain the DNA (figure 7a,b). Only
approximately 3% of wild-type binucleate cells exhibit a
DNA bridge between the two masses of segregating DNA
(figure 7c). By contrast, approximately 25% of fml1D binucle-
ates exhibit a DNA bridge, albeit some of these are
discontinuous and therefore perhaps better described as
DNA tails with a small gap at or near the midpoint between
the main DNA masses (figure 7b,c). The bridges and tails in
the fml1D strain are also on average longer than those seen
in wild-type cells (figure 7d ). A similar frequency and
length of bridges and tails was also seen among fml1D196Nbinucleates, whereas in a fml1AAA mutant their frequency
is less, albeit still fivefold more than in a wild-type
(figure 7c,d ). Altogether these data indicate that Fml1’s cata-
lytic activity and interaction with MHF are needed for the
efficient and timely resolution of DNA connections between
sister chromatids.3.9. MHF localizes to mitotic bridges and tails in a
Fml1-dependent fashion
In human cells, immunostaining for FANCM has revealed
that it forms bridges between segregating DNA in telophase,
suggesting that it plays a role during this late stage of mitosis
to resolve persistent connections between sister chromatids
[31]. Similarly, Mhf1-GFP localizes to more than 90% of the
mitotic DNA bridges or tails detected in wild-type cells by
DAPI staining (figure 7e; electronic supplementary material,
figure S7). This localization is far more striking in fml1D196N
cells, which exhibit a greater frequency and length of bridges
and tails than wild-type (figure 7e; electronic supplementary
material, figure S7). In a few cases, we also observed Mhf1-
GFP localizing to the region between the segregating DNA
masses when no DNA bridge or tail was detected by DAPI
staining (see electronic supplementary material, figure S7).
Importantly, the localization of Mhf1-GFP to mitotic DNA
bridges and tails is lost or greatly diminished in both fml1D
and fml1AAA mutants (see electronic supplementary material,
figure S7). Altogether these data indicate that MHF is recruited
to and/or retained atmitotic DNAbridges and tails through its
interaction with Fml1. The fact that these bridges are occasion-
ally detected in wild-type cells suggests that Fml1 together
with MHF can act as late as mitosis to resolve connections
between sister chromatids.
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Figure 7. Mitotic DNA bridges in wild-type and fml1 mutant cells. (a) Examples of wild-type cells undergoing mitosis. (b) Examples of fml1D mutant cells
exhibiting a mitotic DNA bridge (top row) and tails (bottom row). (c) Frequency of mitotic DNA bridges/tails and (d) length of mitotic DNA bridges in strains
MCW1221, MCW2080, MCW4778 and MCW5895. In all cases, values are mean+s.d. (e) Examples of Mhf1-GFP co-localizing with mitotic DNA bridges/tails in
wild-type (MCW5846) and fml1D196N mutant cells (MCW6132).
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93.10. Mus81–Eme1 functions as a failsafe for
resolving sister chromatid connections in the
absence of Fml1
Even though the frequency of mitotic DNA bridges and tails
increases in a fml1D mutant, this does not lead to a corre-
spondingly high frequency of aberrant chromosome
segregation among cells that have laid down a division
septum (figure 8a,b). This suggests that DNA bridges areresolved prior to cytokinesis. A prime candidate for resolving
DNA junctions between sister chromatids is the Mus81–
Eme1 endonuclease, whose orthologue in budding yeast is
activated during G2 and M phase by CDK- and Polo-like
kinase-dependent phosphorylation of Mms4 (the orthologue
of Eme1) [32,33]. Consistent with Mus81–Eme1 playing an
important role in resolving sister chromatid junctions, a
high frequency (approx. 40%) of mus81D binucleate cells
exhibit mitotic DNA bridges, tails and lagging chromosomes
(see electronic supplementary material, figure S8). Moreover,
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Figure 8. Partial suppression of aberrant chromosome segregation and genotoxin sensitivity in a fml1D mus81D double mutant by deleting rad51. (a) Examples of
aberrant chromosome segregation in septated mus81D (MCW1779) and mus81D fml1D (MCW2428) mutant cells. Arrowheads indicate the division septum.
(b) Frequency of aberrant chromosome segregation among septated cells in strains MCW1221, MCW2080, MCW1088, MCW1779, MCW2428 and MCW4490.
Values are based on the analysis of approximately 300 septated cells from three independent asynchronously growing cultures. (c) Spot assay comparing the
growth and genotoxin sensitivity of strains MCW3792, MCW1235, MCW2428 and MCW4490. Plates were photographed after 5 days growth at 308C.
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10unlike in a fml1D mutant, there is a similarly high number of
septated cells with aberrant chromosomal segregation,
including ‘cut’ (where DNA spans the division septum), mis-
segregation and failed segregation phenotypes (figure 8a,b).
A mus81D fml1D double mutant exhibits a marked reduction
in growth and viability compared with either single mutant
[14], and this correlates with a range of abnormal cell and
nuclear morphologies, including many cells in which the
DNA appears to be fragmented, possibly as a consequence
of aberrant chromosome segregation or as part of an apopto-
tic response. Among septated cells, the frequency of aberrant
chromosome segregation is much higher than in either single
mutant, although it should be noted that the nuclear frag-
mentation, which is prevalent in the double mutant,
complicates this analysis (figure 8b). Altogether these data
indicate that Mus81–Eme1 is able to process the majority of
DNA junctions that would normally be dealt with by Fml1.
In vitro Mus81–Eme1 and Fml1 can process a similar
spectrum of DNA junctions, including model replication
forks and recombination intermediates such as D-loops and
HJs [4,34]. The frequency of aberrant chromosome segre-
gation in a fml1D mus81D double mutant is reduced almost
twofold by deleting rad51 (figure 8b), and rad51 deletion
also partially suppresses the hypersensitivity of a fml1D
mus81D double mutant to ultraviolet (UV) light and MMS,which are agents that induce HR (figure 8c). These data
suggest that much of the impaired chromosome segregation
in a fml1D mus81D mutant is due to unresolved recombina-
tion intermediates that presumably impede sister chromatid
separation. The fact that rad51 deletion does not improve
the growth and viability of a fml1D mus81D mutant more
fully is probably due to Mus81 also having a role in a
Rad51-independent DNA repair pathway [35].4. Discussion
Recent studies have established that vertebrate MHF func-
tions as a component of the CCAN as well as an accessory
factor for FANCM; however, it has been unclear whether
these functions are entirely distinct or overlap. In HeLa
cells, transiently transfected GFP-FANCM localizes to centro-
meres in an MHF1-dependent fashion, suggesting that it
plays a role there in humans [23]. However, we have
shown that, at least in fission yeast, MHF’s function at the
centromere is distinct from its role in supporting Fml1 in
DNA repair and recombination. This conclusion is based on
our observations that Mhf1-GFP localizes to centromeres in
a Fml1-independent manner, and that, unlike a fml1D
mutant, mhf1/2D mutants exhibit poor viability and high
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11rates of meiotic chromosome missegregation. Although these
data do not exclude the possibility that Fml1 functions at cen-
tromeres together with MHF, they do indicate that any role it
might play there is non-essential.
Similar to human MHF, fission yeast MHF binds linear
dsDNA but not ssDNA (see electronic supplementarymaterial,
figure S2; S.B. & M.C.W. 2013, unpublished data), whereas the
helicase domains of both FANCM and Fml1 bind ssDNA and
branched dsDNA structures but not linear dsDNA [4,22]. The
Fml1–MHF complex is therefore endowed with the ability
to bind all of the constituent parts of a stalled replication
fork or D-loop, forming multiple protein–DNA contacts that
presumably enable efficient targeting of these substrates in
vivo. Moreover, the interaction between MHF and FANCM/
Fml1 appears to generate an additional DNA binding site,
which further enhances this ability of the complex [23] (figure
2i). Unsurprisingly, MHF is needed for the localization of
FANCM to chromatin and its efficient recruitment to DNA
ICLs [22,23]. Our data indicate that this dependency is likely
to be reciprocal asMhf1-GFPexhibits reduced or no localization
to non-centromeric chromatin when unable to interact with
Fml1 (because Fml1 is either deleted or mutated in its MHF
interaction domain). Interdependence between both com-
ponents of the FANCM/Fml1–MHF complex for localizing to
non-centromeric chromatin would accord with its synergistic
increase in DNA binding in vitro [22,23].
MHF supports Fml1 in promoting NCO meiotic recombi-
nation and Rad51-dependent recombination at blocked
replication forks [19,22]. We have shown here that it is also
essential for Fml1’s role in CO avoidance during mitotic DSB
repair, and works together with Fml1 in promoting the toler-
ance/repair of both MMS and cisplatin-induced DNA
damage. However, at least for promoting RTS1-induced
direct repeat recombination, it is evident that Fml1 retains
some ability to act without MHF. This is also true in chicken
DT40 cells where deletion of FANCM results in a bigger
increase in SCE than deletion of MHF1 [22]. More surprisingly,
the interaction between Fml1 and MHF, at least mediated by
Fml1’s C-terminal domain, is not essential for MHF to make
a contribution to Fml1-mediated DNA repair and recombina-
tion. Of course, we cannot be certain that the Y672A, R674A
and R678A mutations generated in our study totally prevent
Fml1 from interacting with MHF in vivo, which could occur
additionally via unknown intermediary proteins and/or as a
consequence of post-translational modification.
Replication forks blocked at RTS1 are restarted by a recom-
bination-dependent process [36], and therefore the reduction
in RTS1-induced GC in both fml1D and mhf1/2Dmutants prob-
ably reflects the fact that Fml1–MHF is a key component of the
replication restart machinery. Indeed FANCM’s ATPase
activity has been shown to be important for stabilizing and
restarting stalled replication forks in human cells [37]. Fml1’s
ability to catalyse fork reversal, which is probably enhanced
by MHF, would generate a substrate for the recruitment of
other recombination proteins, leading ultimately to the assem-
bly of a Rad51-DNA filament, which catalyses the key step of
strand invasion that reprimes DNA synthesis [12,14]. Without
a fully functional Fml1–MHF complex replication restart
would be impaired, and this could result in unreplicated
regions of the genome persisting into mitosis, leading to an
increase in mitotic DNA bridges (as observed in fml1D,
fml1D196N and fml1AAA mutants). A similar scenario has been
proposed to explain the increase in ultrafine anaphase bridges(UFBs) detected by immunostaining for the BLM DNA heli-
case in FANCM-depleted cells [31]. However, a failure to
resolve recombination intermediates (i.e. D-loops and HJs)
between sister chromatids could also account for the occur-
rence of mitotic DNA bridges in the fml1 mutants. The
possibility that some UFBs in human cells are caused by unre-
solved recombination intermediates has been largely
discounted because UFB occurrence increases upon deletion
of RAD51 [38]. However, in S. pombe, deletion of Rad51 and
its key mediator Rad52, which together are responsible for
all recombination-dependent replication restart (RDR) [36],
results in a relatively small increase in the frequency of mitotic
DNA bridges compared with a fml1D mutant (L.F. & M.C.W.
2013, unpublished data). Therefore, a failure to promote RDR
cannot account for all of the mitotic DNA bridges that are
observed when Fml1 is absent or impaired.
A failure of FANCM to prevent/resolve UFBs correlates
with an increase in multinucleated cells, which are thought to
arise as a consequence of cytokinesis failure due to DNA
being trapped in the cleavage furrow [31]. In S. pombe, septation
proceeds evenwhen DNA spans the division plane, resulting in
cut phenotypes and uneven distribution of DNA between
daughter cells [39,40]. Interestingly, very few of the mitotic
DNAbridges in a fml1Dmutant give rise to a cut or chromosome
missegregation phenotype, indicating that alternative pathways
of restarting stalled replication forks and processing recombina-
tion intermediates are able to act duringmitosis to achieve sister
chromatid separation prior to septation. At least one of these
pathways appears to depend on Mus81–Eme1 since a mus81D
fml1D double mutant exhibits a synergistic increase in chromo-
some missegregation and cell inviability. Importantly, these
phenotypes are partially suppressed by deleting rad51,
suggesting that some of the aberrant chromosome segregation
is due to unresolved recombination intermediates. Mus81–
Eme1’s ability to act late in the cell cycle to resolve recombination
intermediates accords with the finding in budding yeast that
Mus81–Mms4 nucleolytic activity is activated in G2 and M
phase [32,33]. Intriguingly, while Mus81–Eme1 appears to be
able to resolve most of the recombination intermediates that
accumulate in a fml1D mutant, the reverse is not true, as the
majority of mitotic DNA bridges in amus81Dmutant seemingly
give rise to cut and chromosome missegregation phenotypes.
Single HJs formed during the repair of broken replication
forks may account for these bridges, as neither Fml1 nor RecQ
helicase-dependent doubleHJ dissolutionwould be able to sub-
stitute effectively for Mus81–Eme1 in resolving them
productively [34].
One of the intriguing observations in our study is the
speckled localization of Mhf1-GFP at non-centromeric sites
throughout the nucleus, which depends on MHF’s interaction
with Fml1 but not on Fml1’s ATPase activity. This pattern of
localization is observed in essentially all cells within an asyn-
chronously growing population, and presumably represents
binding of Fml1–MHF or Fml1-dependent deposition of
MHF to multiple genomic sites. Given MHF’s potential to
associate with other histone-fold proteins [22,25], it is possi-
ble that it forms distinct regions of chromatin at sites where
replication forks have been perturbed or recombination
enacted. Such chromatin could persist until its displacement
in the following S-phase. Enrichment of Mhf1-GFP on mitotic
DNA bridges may therefore represent either the redeployment
of Fml1–MHF to replication/recombination intermediates in
M-phase or its retention at these sites following earlier
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12recruitment in S- or G2-phase. The former is certainly possible
because in human cells FANCM has been shown to localize to
UFBs in telophase [31]. Regardless of when it is recruited,
Mhf1-GFP’s presence on bridges suggests that Fml1–MHF is
able to act during the late stages of the cell cycle to promote
sister chromatid segregation.
MHF is a member of a growing list of CCAN proteins that
also function in DNA repair/recombination [41]. It has been
speculated that recombination might play a role in proper cen-
tromere function [42], and if true this would provide a link
between these seemingly disparate processes. However, at
least in the case of MHF, its recombination function, which
is rooted in its interaction with Fml1, is distinct from its key
centromeric role. Nevertheless, it is intriguing to note that
both its functions share a common aim in promoting chromo-
some segregation. Defining the evolutionary origin of this dual
role presents an interesting challenge for future research. 25. Material and methods
5.1. Schizosaccharomyces pombe strains and plasmids
Schizosaccharomyces pombe strains are listed in electronic sup-
plementary material, table S2. The mhf1D::kanMX6 and
mhf2D::natMX4 strains were made by gene targeting using
derivatives of pFA6a-kanMX6 [43] (pMW871) and pAG25
[44] (pMW872), respectively. The initial gene deletion was
made in adiploidS. pombe strain fromwhich haploid segregants
were obtained.Themhf1::GFP-kanMX6 strainwasmadebygene
targeting directly in a haploid S. pombe strain using a deriva-
tive of pFA6a-GFP(S65 T)-kanMX6 [43] (pCB1). Similarly,
fml1AAA::natMX4, fml1DC1–603::natMX4, fml1þ::13Myc-natMX4,
fml1AAA::13Myc-natMX4 and fml1DC1–603::13Myc-natMX4
strains were made by gene targeting in a haploid S. pombe
strain using derivatives of pAG25 (pJBB79, pJBB9, pJBB28,
pJBB81 and pJBB7, respectively). The plasmids for expressing
full-length or fragments of Fml1 fused toMBPare all derivatives
of pMAL-c2x (New England BioLabs) with a BamHI–XbaI
insert encoding the stated portion of Fml1. The plasmid for
co-expressing Mhf1 and His-tagged Mhf2 (pMW891) was
made by first cloning the cDNA for mhf2 as an NdeI–BamHI
fragment into pET14b tomake pMW884. A BglII–SalI fragment
containing the T7 promoter and mhf1 cDNA from the pT7-7
derivative pMW889 was then cloned into these sites in
pMW884. The plasmid for co-expressing Mhf1, His-tagged
Mhf2 and Fml1576–725 (pCB6) was made by amplifying the T7
promoter and fml1576–725 fragment from the pT7-7 derivative
pCB5 and cloning this as a NheI fragment into pMW891. All
plasmids were verified by DNA sequencing.
5.2. Media and genetic methods
Media and genetic methods followed standard protocols [45].
The complete and minimal media were yeast extract with
supplements (YES) and Edinburgh minimal medium plus
3.7 mg ml21 sodium glutamate (EMMG), plus appropriate
amino acids (0.25 mg ml21), respectively. Sporulation of
crosses was performed on malt extract agar (MEA). Low ade-
nine media (YELA) was supplemented with 0.01 mg ml21
adenine. Adeþ recombinants were selected on YES lacking
adenine and supplemented with 0.2 mg ml21 guanine to
prevent uptake of residual adenine.5.3. Spot assays
Exponentially growing cells from liquid cultures were har-
vested, washed and resuspended in water at a density of
1107–1103 cellsml21. Aliquots (10 ml) of the cell suspen-
sions were spotted onto YES agar plates containing
genotoxins as indicated. For UV, plates were irradiated
using a Stratalinker (Stratagene). Plates were photographed
after 3–5 days growth at 308C as indicated.
5.4. Microscopy
Cells from an exponentially growing culture in YES were
harvested and fixed with 70% ethanol for subsequent
microscopy. The fixed cells were stained with DAPI and ana-
lysed using an Olympus BX50 epifluorescence microscope
equipped with the appropriate filter sets to detect blue,
green and red fluorescence (Chroma Technology, VT). Black
and white images were acquired with a CoolSNAP HQ2
CCD camera (Photometrics, AZ) controlled by METAMORPH
software (v. 7.7.3.0, Molecular Devices, CA). Images were
pseudo-coloured and overlayed using PHOTOSHOP CS5
(v. 12.0, Adobe Systems, CA).
5.5. Recombination assays
The direct repeat recombination, plasmid gap repair and
meiotic recombination assays have been described previously
[14,30,46,47]. Two sample t-tests were used to determine the
statistical significance of differences in recombination values
between strains unless otherwise stated.
5.6. Protein expression and purification
A 1 l culture of E. coli BL21 (DE3) CodonPlus-RIL cells (Strata-
gene) transformed with pMW891 was grown with aeration at
258C in LB broth containing 50 mgml–1 ampicillin and
20 mg ml21 chloramphenicol to an A600 of 0.5. Mhf1-HisMhf2
was induced by adding IPTG to a final concentration of
0.5 mM, following which the cells were grown with aeration
at 258C for a further 5 h. The cells were then harvested by cen-
trifugation, resuspended in 20 ml Buffer H (50 mM potassium
phosphate, pH 8.0, 0.3 M NaCl, 10% glycerol) and frozen at
2808C until needed. The frozen cells were defrosted and
mixed with 1% Triton X-100, 10 mM b-mercaptoethanol and
EDTA-free protease inhibitor cocktail (Roche) before passage
through a French pressure cell at 19 000 p.s.i. All subsequent
steps were performed at 48C. The lysates were cleared by cen-
trifugation at 19 000g for 50 min, and the supernatant was
loaded directly onto a 1 ml nickel-nitrilotriacetic acid Super-
flow column (Qiagen) that had been pre-equilibrated with
Buffer H. The column was then washed with 60 ml of Buffer
H plus 20 mM imidazole before eluting bound Mhf1-
HisMhf2 with Buffer H plus 100 mM imidazole into three
1 ml fractions. The second 1 ml fraction contained the peak
of Mhf1-HisMhf2 and was loaded directly onto a HiLoad
16/60 Superdex 200 gel filtration column (Amersham
Biosciences), which was then developed with 120 ml of
Buffer A (50 mM Tris–HCl, pH8.0, 1 mM EDTA, 1 mM DTT,
10% glycerol) plus 0.3 M NaCl. Fractions of 2ml were col-
lected, and the peak fractions containing Mhf1-HisMhf2
(fractions 36–42) were pooled, diluted with an equal volume
of Buffer A and loaded onto a 1 ml Hi-Trap Heparin column
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13(GE Healthcare). The column was then washed with 5 ml of
Buffer A plus 0.1 M NaCl before eluting bound protein with
an 18 ml linear gradient from 0.1 to 1.0 M NaCl. The peak of
Mhf1-HisMhf2 eluted between 0.41 and 0.43 M NaCl, and
these fractions were pooled and stored as aliquots at 2808C.
The purification of Fml1576–725-Mhf1-HisMhf2 followed
the same protocol as for Mhf1-HisMhf2 except the expression
plasmid was pCB6 and the final heparin step was omitted.
The peak of Fml1576–725-Mhf1-HisMhf2 eluted from the gel
filtration column in fractions 34–36, and these fractions
were pooled and stored as aliquots at 2808C.
Both full-length Fml1 and fragments of it were expressed
as fusion proteins with MBP from the appropriate pMAL-c2x
derivative in BL21 (DE3) CodonPlus-RIL cells. Cells were
grown as 100 ml cultures at 258C with aeration in LB broth
containing 50 mg ml21 ampicillin and 20 mg ml21 chloram-
phenicol. At a cell density corresponding to an A600 of 0.6,
IPTG was added to a final concentration of 250 mM and incu-
bation continued for a further 12 h at 188C. Cells were then
harvested by centrifugation and resuspended in 10 ml of
Buffer M (20 mM Tris–HCl, pH 7.4, 200 mM NaCl, 1 mM
EDTA, 10% glycerol). DTT (1 mM), Triton X-100 (1%) and
PMSF (4 mM) were added to the sample before it was lysed
by passage through a French pressure cell at 19 000 p.s.i.
All subsequent steps were performed at 48C. Cell debris
was removed by centrifugation at 19 000g and the cleared
lysate was then loaded onto a 0.5 ml amylose column (New
England Biolabs) pre-equilibrated with Buffer M, which
was then washed with 12 ml of Buffer M before eluting
bound protein with Buffer M plus 10 mM maltose. Protein
samples were pooled and stored as aliquots at 2808C.
In all cases, protein amounts were estimated using a
Bio-Rad protein assay kit with bovine serum albumin as
the standard.
5.7. Protein–protein interaction assay
Full-length Fml1 and fragments of Fml1 fused to MBP were
immobilized on 100 ml amylose resin by incubating themfor 2 h at 48C on a rotating wheel. After removing unbound
protein by washing with Buffer M, purified Mhf1-HisMhf2
was added and the mixture incubated for 3 h at 48C on a
rotating wheel. Unbound protein was removed by three con-
secutive 20min washes with 0.5 ml Buffer M before eluting
bound protein with Buffer M plus 10 mM maltose. Samples
were then analysed for the presence of Mhf1-HisMhf2 by
Western blotting using anti-polyhistidine antibody (Sigma).5.8. DNA substrates
The 32P-labelled linear dsDNA substrate was made by
annealing oligonucleotides 2 and 44 (50-CAACGTCATAGAC
GATTACATTGCTAGGACATCTTTGCCCACGTTGACCC-30)
as described by Whitby & Dixon [48].5.9. DNA binding assays
Reaction mixtures (20 ml) contained 1.1 nM 32P-labelled linear
duplex DNA in buffer (25 mM Tris–HCl, pH 8.0, 1 mM DTT,
100 mg ml21 bovine serum albumin, 6% glycerol) plus
protein as indicated. Reactions were incubated on ice for
15 min and then loaded onto a 4% native polyacrylamide
gel in low-ionic-strength buffer (6.7 mM Tris–HCl, pH 8.0,
3.3 mM sodium acetate, 2 mM EDTA) that had been pre-
cooled at 48C. Gels were run for 1 h and 45 min at 160 V
with continuous buffer recirculation. Gels were then dried
on 3 MM Whatman paper and analysed by Phosphor
Imaging using a Fuji FLA3000 and IMAGE GAUGE software.Acknowledgements. We thank Zsofi Novak for constructing strain
MCW4490, Elizabeth Murray for help with the mitotic DNA bridge
analysis, and Stefania Castagnetti and Mitsuhiro Yanagida for
supplying strains.
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Supplementary Table S1. Frequency of gene conversion and crossing over in the 
ura4+-aim2 – ade6 – his3+-aim interval. 
The values are the means from n independent crosses and the values in brackets are 
the standard deviations. The number of Ade+ recombinants tested is indicated, as is 
the total number of viable spores analyzed for crossing over between ura4+-aim2 and 
his3+-aim. ade6-3083 is a known hot spot for recombination and therefore acts 
predominantly as a recipient of genetic information, this and the order of markers 
explains the disparity between P1/R1 and P2/R2 classes. CentiMorgan (cM) are 
calculated from the accumulated data of the independent crosses, not from the mean 
values, using the mapping function of Haldane. P values are calculated using a two-
tailed Mann-Whitney U test in G*Power 3.1 against the data from the wild-type cross 
(MCW3202 × MCW3200) assuming a power of 1 – β = 0.8. 
Cross % ade+               Crossovers 
(CO)  
strain genotype 
 
n 
 
Frequency 
of ade+ in 
% 
 
ade+ 
tested ura-
his+    
(P1) 
ura+his-    
(P2) 
ura-
his-      
(R1) 
ura+his+     
(R2) 
tested Frequency 
of CO in 
% 
cM 
MCW3202 
× 
MCW3200 
wild-type 6 1.465 
(0.159) 
1,452 3.21 
(1.12) 
38.08 
(3.32) 
55.05 
(3.8) 
3.66 
(1.52) 
1,160 15.457 
(2.316) 
18.83 
MCW4174 
× 
MCW4173 
fml1∆::natMX4 10 1.036a 
(0.084) 
2,130 6.62b 
(1.97) 
19.82b 
(2.93) 
70.93b 
(2.96) 
2.63b 
(1.03) 
2,519 21.463c 
(3.55) 
28.48 
MCW6215 
× 
MCW6214 
fml1+::natMX4 6 1.456 
(0.151) 
1,503 2.86 
(0.99) 
31.45 
(1.05) 
63.55 
(1.49) 
2.14 
(0.78) 
1,367 14.958 
(3.191) 
17.93 
MCW6142 
× 
MCW6141 
fml1AAA::natMX4 6 1.694d 
(0.132) 
1,409 6.13e 
(1.14) 
19.86e 
(3.45) 
72.04e 
(4.07) 
1.97e 
(0.95) 
1,252 20.927f 
(2.19) 
27.11 
a P = 2.29 × 10-3, highly significant; b 3.67 × 10-5, highly significant; c P = 0.051, not significant. 
d P = 0.102, not significant; e  6.28 × 10-3, highly significant; f P = 0.031, significant at an α-level of 0.05. 
 
 
 
 
Supplementary Table S2. S. pombe strains used in this study  
Strain Relevant genotype Source 
MCW1088 h+ rad51∆::arg3+ura4-D18 leu1-32 his3-D1 arg3-D4 (Doe et al, 2004) 
MCW1193 h+ ade6-M26 ura4-D18 leu1-32 his3-D1 arg3-D4 lab strain 
MCW1221 h+ ura4-D18 leu1-32 his3-D1 arg3-D4 lab strain 
MCW1235 h+ mus81∆::KanMX6 rad51∆::arg3+ura4-D18 leu1-32 
his3-D1 arg3-D4 
(Doe et al, 2004) 
MCW1779 h+ mus81∆::arg3+ ura4-D18 leu1-32 his3-D1 arg3-D4 lab strain 
MCW2080 h+ fml1∆::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 (Sun et al, 2008) 
MCW2096 h+ fml1∆::natMX4 ade6-M26 ura4-D18 leu1-32 his3-
D1 arg3-D4 
(Sun et al, 2008) 
MCW2428 h+ fml1∆::natMX4 mus81∆::arg3+ ura4-D18 leu1-32 
his3-D1 arg3-D4 
(Sun et al, 2008) 
MCW3061 h+ fml1∆::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 
ade6-M375 int::pUC8/his3+/RTS1 site A orientation 
2/ade6-L469 
(Sun et al, 2008) 
MCW3200 h-smt0 ade6-L469 his3+-aim ura4-D18 his3-D1 arg3-D4 (Lorenz et al, 2010) 
MCW3202 h+ ade6-3083 ura4+-aim2 ura4-D18 his3-D1 arg3-D4 (Lorenz et al, 2010) 
MCW3792 h+ fml1∆::natMX4 rad51∆::arg3+ura4-D18 leu1-32 
his3-D1 arg3-D4 
this study 
MCW4172 h-smt0 fml1∆::natMX4 ura4-D18 leu1-32 his3-D1 arg3-
D4 
this study 
MCW4173 h-smt0 fml1∆::natMX4 ade6-L469 his3+-aim ura4-D18 
his3-D1 arg3-D4 
this study 
MCW4174 h+ fml1∆::natMX4 ade6-3083 ura4+-aim2 ura4-D18 
his3-D1 arg3-D4 
this study 
MCW4405 h+ fml1∆C1-603::natMX4 ura4-D18 leu1-32 his3-D1 
arg3-D4 
this study 
MCW4406 h+ fml1+::13-Myc-natMX4 ura4-D18 leu1-32 his3-D1 
arg3-D4 
this study 
MCW4407 h+ fml1∆C1-603::13-Myc-natMX4 ura4-D18 leu1-32 his3-
D1 arg3-D4 
this study 
MCW4490 h+ fml1∆::natMX4 mus81∆::KanMX6 
rad51∆::arg3+ura4-D18 leu1-32 his3-D1 arg3-D4 
this study 
MCW4581 h+ fml1+::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 this study 
MCW4639 h+ mhf1∆::kanMX6 ura4-D18 leu1-32 his3-D1 arg3-D4 this study 
MCW4713 h+ ura4-D18 leu1-32 his3-D1 arg3-D4 ade6-M375 
int::pUC8/his3+/RTS1 site A orientation 2/ade6-L469 
lab strain 
MCW4770 h+ mhf1∆::kanMX6 ura4-D18 leu1-32 his3-D1 arg3-D4 
ade6-M375 int::pUC8/his3+/RTS1 site A orientation 
2/ade6-L469 
this study 
MCW4777 h- mhf2∆::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 this study 
MCW4778 h+ fml1D196N::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 (Nandi & Whitby, 
2012) 
MCW4797 h+ fml1+::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 
ade6-M375 int::pUC8/his3+/RTS1 site A orientation 
2/ade6-L469 
(Nandi & Whitby, 
2012) 
MCW4893 h+ fml1+::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 
ade6-M26  
(Nandi & Whitby, 
2012) 
MCW5074 h+ sad1+::DsRED-kanMX6 ura4-D18 leu1-32 his3-D1 
arg3-D4 
lab strain 
MCW5076 h+ mis6+::mCherry-kanMX6 ura4-D18 leu1-32 his3-D1 
arg3-D4 
lab strain 
MCW5113 h+ mhf2∆::natMX4 lys1+::lacO his7+::lacI-GFP ura4-
D18 leu1-32 arg3-D4 
this study 
MCW5126 h+ mhf2∆::natMX4 fml1∆::hphMX4 ura4-D18 leu1-32 
his3-D1 arg3-D4 
this study 
MCW5127 h+ mhf1∆::kanMX6 mhf2∆::natMX4 ura4-D18 leu1-32 
his3-D1 arg3-D4 
this study 
MCW5217 h+ mhf2∆::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 
ade6-M375 int::pUC8/his3+/RTS1 site A orientation 
2/ade6-L469 
this study 
MCW5218 h+ mhf1∆::kanMX6 fml1∆::hphMX4 ura4-D18 leu1-32 
his3-D1 arg3-D4 ade6-M375 int::pUC8/his3+/RTS1 site 
A orientation 2/ade6-L469 
this study 
MCW5220 h+ mhf2∆::natMX4 fml1∆::hphMX4 ura4-D18 leu1-32 
his3-D1 arg3-D4 ade6-M375 int::pUC8/his3+/RTS1 site 
A orientation 2/ade6-L469 
this study 
MCW5345 h+ mhf1∆::kanMX6 ade6-M26 ura4-D18 leu1-32 his3-
D1 arg3-D4 
this study 
MCW5346 h+ mhf2∆::natMX4 ade6-M26 ura4-D18 leu1-32 his3-
D1 arg3-D4 
this study 
MCW5790 h+ mhf1∆::kanMX6 fml1∆::hphMX4 ade6-M26 ura4-D18 
leu1-32 his3-D1 arg3-D4 
this study 
MCW5846 h+ mhf1::GFP-kanMX6 mis6::mCherry-ura4+ ura4-D18 
leu1-32 his3-D1 arg3-D4 
this study 
MCW5895 h+ fml1AAA::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 this study 
MCW5896 h+ fml1AAA::13-Myc-natMX4 ura4-D18 leu1-32 his3-D1 
arg3-D4 
this study 
MCW5932 h+ fml1AAA::natMX4 ura4-D18 leu1-32 his3-D1 arg3-D4 
ade6-M375 int::pUC8/his3+/RTS1 site A orientation 
2/ade6-L469 
this study 
MCW5963 h+ fml1∆::hphMX4 mhf1::GFP-kanMX6 mis6::mCherry-
ura4+ ura4-D18 leu1-32 his3-D1 arg3-D4 
this study 
MCW5983 h+ mhf2∆::natMX4 fml1∆::hphMX4 ade6-M26 ura4-D18 
leu1-32 his3-D1 arg3-D4 
this study 
MCW6001 h+ fml1AAA::natMX4 ade6-M26 ura4-D18 leu1-32 his3-D1 
arg3-D4 
this study 
MCW6132 h+ fml1D196N::natMX4 mhf1::GFP-kanMX6 
mis6::mCherry-ura4+ ura4-D18 leu1-32 his3-D1 arg3-D4 
this study 
MCW6141 h-smt0 fml1AAA::natMX4 ade6-L469 his3+-aim ura4-D18 
his3-D1 arg3-D4 
this study 
MCW6142 h+ fml1AAA::natMX4 ade6-3083 ura4+-aim2 ura4-D18 
his3-D1 arg3-D4 
this study 
MCW6152 h+ fml1AAA::natMX4 mhf1::GFP-kanMX6 mis6::mCherry-
ura4+ ura4-D18 leu1-32 his3-D1 arg3-D4 
this study 
MCW6196 h+  fml1∆::natMX4 lys1+::lacO his7+::lacI-GFP this study 
MCW6214 h-smt0 fml1+::natMX4 ade6-L469 his3+-aim ura4-D18 his3-
D1 arg3-D4 
this study 
MCW6215 h+ fml1+::natMX4 ade6-3083 ura4+-aim2 ura4-D18 his3-
D1 arg3-D4 
this study 
FO808 h- ura4-D18 leu1-32 his3-D1 arg3-D4  lab strain 
AY167-1D h- ade6-M210 leu1-32 ura4-D18 lys1+::lacO his7+::lacI-
GFP 
M. Yanagida 
 
 
 
 
 
 
 
 
 
Figure S1. Co-localization of GFP-Mhf1 and GFP-Mhf2 with Mis6-mCherry. (A) 
Example cell showing the co-localization of GFP-Mhf1, expressed from a derivative 
of pREP41-EGFPN (Craven et al, 1998) (pJBB45), with Mis6-mCherry in strain 
MCW5076. (B) Example cell showing the co-localization of GFP-Mhf2, expressed 
from a derivative of pREP41-EGFPN (pJBB46), with Mis6-mCherry in strain 
MCW5076. 
 
 
 
Figure S2. DNA binding by MHF and mapping its interaction site on Fml1. (A) 
Purification of recombinant MHF. SDS-PAGE analysis of samples from the various 
stages of the MHF purification. The gel was stained with coomassie blue. (B) 
Schematic of Fml1 and the various truncated forms of it used in (C). (C) Western blot 
showing the amount of His-tagged Mhf2 retained on amylose resin pre-incubated with 
the indicated MBP-Fml1 fragment (the numbers refer to amino acid positions). (D) 
EMSA showing the binding of MHF  (lanes b to f: 0.37 µM, 0.74 µM, 1.48 µM, 2.96 
µM and 3.7 µM) to linear dsDNA. 
 
 
 
 
Figure S3. The MMS hypersensitivity of fml1∆C1-603 and fml1AAA mutants is not due to 
an altered level of protein. (A and C) Spot assays comparing the MMS sensitivity of 
strains MCW1221, MCW4406, MCW2080, MCW4407 and MCW5896. The MMS 
sensitivity of a fml1+-13myc strain is similar to wild-type, whereas fml1∆C1-603-13myc 
and fml1AAA-13myc mutants exhibit hypersensitivity that is intermediate between wild-
type and fml1∆ like the equivalent strains without a 13myc tag. (B and D) Western 
blots comparing the amounts of 13myc-tagged Fml1 in whole-cell protein extracts 
(Matsuo et al, 2006) from the same strains used in (A) and (C).  Blots were probed 
with a polyclonal anti-myc antibody (Abcam). The loading controls are shown in the 
bottom panels. 
 
 
 
 
Figure S4. Relative efficiency of plasmid gap repair and GC in strains MCW1193, 
MCW2096, MCW5345, MCW5346, MCW5790, MCW5983, MCW4893 and 
MCW6001. (A) Histogram showing the percentage of Ura+ transformants that are 
Ade+ recombinants. These data indicate that the frequency of GC during plasmid gap 
repair is similar in all of the strains tested here. (B) Histogram showing the 
transformation efficiency (TE) of cut versus uncut plasmid in the various mutant 
strains relative to wild-type. These data indicate that plasmid gap repair is similarly 
efficient in all of the strains tested here. All values are means from three experiments 
+/-SD. 
 
 
 
 
Figure S5. Nuclear localization of Mhf1-GFP in wild-type and fml1 mutant cells. The 
strains are MCW5846, MCW5963, MCW6152 and MCW6132. 
 
 
 
 
 
Figure S6. Western blot comparing the amounts of Mhf1-GFP in whole-cell protein 
extracts (Matsuo et al, 2006) from strains MCW1221, MCW5846, MCW5963, 
MCW6152 and MCW6132. The blot was probed with a monoclonal anti-GFP 
antibody (Clontech Laboratories Inc.). 
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Figure S7. Representative examples of Mhf1-GFP co-localizing with mitotic DNA 
bridges/tails in (A) wild-type (MCW5846) and (B) fml1D196N (MCW6132) mutant cells 
and failing to localize with mitotic DNA bridges/tails in (C) fml1∆ (MCW5963) and 
Strain Number of DAPI-stained mitotic 
DNA bridges/tails analysed 
Number of mitotic DNA bridges/tails with 
detectable levels of co-localizing Mhf1-GFP 
wild-type 21 20 
fml1D196N 39 36 
fml1∆ 29 0 
fml1AAA 20 1 
(D) fml1AAA (MCW6152) mutant cells. The top panels in (B) show an example of 
Mhf1-GFP localizing to the region between the segregating DNA masses where there 
is no discernible DAPI staining. This may be analogous to the UFBs that FANCM 
localizes to in human cells. (E) Number of mitotic DNA bridges/tails analysed for the 
presence/absence of Mhf1-GFP. 
 
 
 
 
 
Figure S8. Mitotic DNA bridges/tails and lagging chromosomes in a mus81∆ mutant 
(MCW1779). Example of a mus81∆ mutant cell with a mitotic DNA bridge (left hand 
panel). Frequency of binucleate mus81∆ cells with a mitotic DNA bridge/tail or 
lagging chromosome (right hand panel). Values are means +/-SD. 
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